These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension. Mallion JM; Goldberg AI Blood Press Suppl; 1996; 2():82-6. PubMed ID: 8913546 [TBL] [Abstract][Full Text] [Related]
23. [Changed guidelines of the German High Blood Pressure League. AT(1) blocker in the first league now]. MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494603 [No Abstract] [Full Text] [Related]
24. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy. Neutel J; Shojaee A; Maa JF Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358 [TBL] [Abstract][Full Text] [Related]
25. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension. Chrysant SG Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666 [TBL] [Abstract][Full Text] [Related]
26. [Angiotensin II receptor antagonists]. Bornkessel B Med Monatsschr Pharm; 1995 Jun; 18(6):148-51. PubMed ID: 7609710 [No Abstract] [Full Text] [Related]
27. [AT1 receptor antagonists in treatment of hypertension]. Franz IW Fortschr Med; 1997 Jul; 115(19):38-40. PubMed ID: 9333581 [No Abstract] [Full Text] [Related]
28. Angiotensin II receptor inhibition. A new therapeutic principle. Messerli FH; Weber MA; Brunner HR Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149 [TBL] [Abstract][Full Text] [Related]
29. [Preferences in general practice. Interview by Christine Vetter]. Holzgreve H Fortschr Med; 1998 May; 116(13):44-5. PubMed ID: 9630784 [No Abstract] [Full Text] [Related]
30. Losartan and angina pectoris. Ahmad S Tex Heart Inst J; 1995; 22(4):347-8. PubMed ID: 8605440 [No Abstract] [Full Text] [Related]
31. Olmesartan medoxomil: recent clinical and experimental acquisitions. Destro M; Preti P; D'Ospina A; Christian Achiri NN; Ricci AR; Cagnoni F Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1149-57. PubMed ID: 19689219 [TBL] [Abstract][Full Text] [Related]
32. Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study. Lacourcière Y; Lefebvre J; Nakhle G; Faison EP; Snavely DB; Nelson EB J Hypertens Suppl; 1994 Jul; 12(2):S49-53. PubMed ID: 7965266 [TBL] [Abstract][Full Text] [Related]
33. Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide. Rump LC; Sellin L Expert Opin Pharmacother; 2010 Sep; 11(13):2231-42. PubMed ID: 20707758 [TBL] [Abstract][Full Text] [Related]
37. [Angiotensin receptor antagonists. A new class of antihypertensive agents]. Mann J Dtsch Med Wochenschr; 1996 Apr; 121(17):568-71. PubMed ID: 8620827 [No Abstract] [Full Text] [Related]
38. Aliskiren/valsartan (Valturna) for hypertension. Med Lett Drugs Ther; 2009 Nov; 51(1326):94-5. PubMed ID: 20224524 [No Abstract] [Full Text] [Related]